Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
| 4.12 Delayed Data As of Aug 04 |  -0.01 / -0.24%Today’s Change | 2.55 Today|||52-Week Range 7.67 | +9.87% Year-to-Date |
Latest CPRX News | Press Releases
| Catalyst Pharma down 13% on adverse ruling in FDA lawsuit Jul 31 / Seeking Alpha - Paid Partner Content | Robinhood Investors Love These 3 Small-Cap Biotech Stocks Jul 26 / MotleyFool.com - Paid Partner Content |
| TAOP, KODK among premarket losers Jul 31 / Seeking Alpha - Paid Partner Content | Catalyst Pharma files for $200M mixed shelf Jul 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 4.13 |
| Today’s open | 4.08 |
| Day’s range | 4.06 - 4.17 |
| Volume | 98,897 |
| Average volume (3 months) | 1,779,146 |
| Market cap | $444.7M |
Data as of 3:59pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +25.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +20,361.27% |
| P/E ratio | 10.0 |
| Price/Sales | 3.89 |
| Price/Book | 5.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBYIPuma Biotechnology I... | -0.11 | -1.01% |
| NLTXNeoleukin Therapeuti... | -0.07 | -0.68% |
| SPPISpectrum Pharmaceuti... | +0.22 | +7.12% |
| ---- |
Data as of 4:00pm ET, 08/04/2020
Financials
| Next reporting date | August 11, 2020 |
| EPS forecast (this quarter) | $0.09 |
| Annual revenue (last year) | $102.3M |
| Annual profit (last year) | $31.9M |
| Net profit margin | 31.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Coral Gables, Florida |
Forecasts
